Question for the board - What is the minimum pop (in % terms) that anyone remembers seeing for a small biotech (i.e. existing revenues less than $15M per year) that just announced a successful ph iii trial with no obvious safety issues?
I ask because I am actually surprised that VVUS went up about 75% - since it is was almost certain to be stat sig and the safey issue, while not as certain, wasn't too much of a risk. Maybe that is just the min size for a ph iii pop?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.